What is the Kolon TissueGene stock price forecast?

Kolon TissueGene is currently trading at ₩15,000. View real-time AI analysis on Alpha Lenz.

What is Kolon TissueGene insider trading activity?

View the latest insider trading data for Kolon TissueGene on Alpha Lenz.

What is Kolon TissueGene's P/E ratio?

Kolon TissueGene's P/E ratio is -6.4.

Kolon TissueGene

KRX · 950160

₩15,000-6,050(-28.74%)Market closed

Ask about Kolon TissueGene's future dividend policy...

Alpha Chat Insight

“Kolon TissueGene trades at a P/E of -6.4 (undervalued) with modest ROE of -183.4%.”

Ask for details →

Company Overview

CEO노문종, 전승호

Websitehttps://www.tissuegene.com

SectorCommon Stock

IndustryCommon Stock

Company Statistics

FY 2025

Profile

₩1,274,552,400,000Market Cap

₩5,158,705,000Revenue

84.97MShares Out

0Employees

Margins

13.28%Gross

-408.88%EBITDA

-432.73%Operating

-3732.85%Pre-Tax

-3733.25%Net

Valuation

-6.40P/E

19.23P/B

238.92EV/Sales

-58.99EV/EBITDA

-8.71P/FCF

Growth (CAGR)

-18.29%Rev 3Yr

7.73%Rev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-59.60%ROA

-183.43%ROE

-59.56%ROIC

Financial Health

₩67,742,227,000Cash & Cash Equivalents

₩292,167,012,000Net Debt

561.65%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Kolon TissueGene trades at a P/E of -6.4 (undervalued) with modest ROE of -183.4%.”

Ask for details →

Frequently Asked Questions

Kolon TissueGene (ticker: 950160) is a company listed on KRX in the Common Stock sector (Common Stock). Market cap is $1.3T.

The current price is ₩15,000 with a P/E ratio of -6.4x and P/B of 19.23x.

ROE is -183.43% and operating margin is -432.73%. Annual revenue is $5.2B.